Nanobiotix Raises $11 Million
Nanobiotix, a Paris-based developer of nanotech-based cancer therapeutics, has raised $11 million in Series C funding. CIC Vizille Capital Innovation led the round, and was joined by Masseran Gestion and return backers Matignon Technologies, OTC Asset Management, Cap Decisif Management and Amorçage Rhône-Alpes.
4 May 2010•3 mins read
